by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Woodbine Products Company Inc. Warning Letter Details

Warning Letter

Woodbine Products Company Inc.

915 W. Smith Road Medina , OH 44256-2446 United States

Issue DateJuly 27, 2026

FEI Number1519202

Violations4

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Woodbine Products Company Inc. FDA Warning Letter, July 27, 2026